首页> 外文期刊>Asian Journal of Chemistry: An International Quarterly Research Journal of Chemistry >Development of Dissolution Medium for Rofecoxib in Pharmaceutical Formulations
【24h】

Development of Dissolution Medium for Rofecoxib in Pharmaceutical Formulations

机译:药物制剂中罗非昔布溶出介质的开发

获取原文
获取原文并翻译 | 示例
       

摘要

Rofecoxib is a non-steroidal antiinflammatory drug and selective cox-2 inhibitor,used in the treatment of rheumatoid arthritis especially in gastritis and ulcerative conditions.It is chemically designated as 4-[4-(methylsulfonyl)phenyl]-3-phenyl-2-(5H)-furanone.In this present study,dissolution of rofecoxib from two commercial formulations was studied in two different media to evaluate their discriminating power.
机译:罗非考昔是一种非甾体类抗炎药和选择性cox-2抑制剂,用于类风湿性关节炎的治疗,尤其是在胃炎和溃疡性疾病中。它的化学名称为4- [4-(甲基磺酰基)苯基] -3-苯基-2 -(5H)-呋喃酮。在本研究中,在两种不同的介质中研究了两种商业制剂中罗非昔布的溶出度,以评估其辨别力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号